Foreign-Trade Zone (FTZ) 153-San Diego, California; Authorization of Production Activity; Ajinomoto Bio-Pharma Services (Pharmaceutical Products), San Diego, California, 1353 [2023-00307]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 88, No. 6 / Tuesday, January 10, 2023 / Notices participate in any way in any transaction involving any commodity, software or technology (hereinafter collectively referred to as ‘‘item’’) exported or to be exported from the United States that is subject to the Regulations, including, but not limited to: A. Applying for, obtaining, or using any license, license exception, or export control document; B. Carrying on negotiations concerning, or ordering, buying, receiving, using, selling, delivering, storing, disposing of, forwarding, transporting, financing, or otherwise servicing in any way, any transaction involving any item exported or to be exported from the United States that is subject to the Regulations, or engaging in any other activity subject to the Regulations; or C. Benefitting in any way from any transaction involving any item exported or to be exported from the United States that is subject to the Regulations, or from any other activity subject to the Regulations. Second, no person may, directly or indirectly, do any of the following: A. Export, reexport, or transfer (incountry) to or on behalf of the Denied Person any item subject to the Regulations; B. Take any action that facilitates the acquisition or attempted acquisition by the Denied Person of the ownership, possession, or control of any item subject to the Regulations that has been or will be exported from the United States, including financing or other support activities related to a transaction whereby the Denied Person acquires or attempts to acquire such ownership, possession or control; C. Take any action to acquire from or to facilitate the acquisition or attempted acquisition from the Denied Person of any item subject to the Regulations that has been exported from the United States; D. Obtain from the Denied Person in the United States any item subject to the Regulations with knowledge or reason to know that the item will be, or is intended to be, exported from the United States; or E. Engage in any transaction to service any item subject to the Regulations that has been or will be exported from the United States and which is owned, possessed or controlled by the Denied Person, or service any item, of whatever origin, that is owned, possessed or controlled by the Denied Person if such service involves the use of any item subject to the Regulations that has been or will be exported from the United States. For purposes of this paragraph, VerDate Sep<11>2014 17:32 Jan 09, 2023 Jkt 259001 servicing means installation, maintenance, repair, modification or testing. Third, pursuant to Section 1760(e) of ECRA (50 U.S.C. 4819(e)) and Sections 766.23 and 766.25 of the Regulations, any other person, firm, corporation, or business organization related to Veletanlic by ownership, control, position of responsibility, affiliation, or other connection in the conduct of trade or business may also be made subject to the provisions of this Order in order to prevent evasion of this Order. Fourth, in accordance with part 756 of the Regulations, Veletanlic may file an appeal of this Order with the Under Secretary of Commerce for Industry and Security. The appeal must be filed within 45 days from the date of this Order and must comply with the provisions of part 756 of the Regulations. Fifth, a copy of this Order shall be delivered to Veletanlic and shall be published in the Federal Register. Sixth, this Order is effective immediately and shall remain in effect until January 27, 2030. John Sonderman, Director, Office of Export Enforcement. [FR Doc. 2023–00272 Filed 1–9–23; 8:45 am] BILLING CODE 3510–DT–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–42–2022] Foreign-Trade Zone (FTZ) 153—San Diego, California; Authorization of Production Activity; Ajinomoto BioPharma Services (Pharmaceutical Products), San Diego, California On September 7, 2022, the City of San Diego, grantee of FTZ 153, submitted a notification of proposed production activity to the FTZ Board on behalf of Ajinomoto Bio-Pharma Services, within FTZ 153, in San Diego, California. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 56626, September 15, 2022). On January 5, 2023, the applicant was notified of the FTZ Board’s decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board’s regulations, including Section 400.14. PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 1353 Dated: January 5, 2023. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2023–00307 Filed 1–9–23; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Bureau of Industry and Security In the Matter of: Nathan Christopher Ball, 6601 Fountain Hills Place, El Paso, TX 79932; Order Denying Export Privileges On November 6, 2019, in the U.S. District Court for the District of New Mexico, Nathan Christopher Ball (‘‘Ball’’) was convicted of violating 18 U.S.C. 371 and 18 U.S.C. 554(a). Specifically, Ball was convicted of conspiring to smuggle from the US to Mexico, firearms and ammunition without the required license or written authorization. As a result of his conviction, the Court sentenced Ball to 27 months of confinement, two years of supervised release, $300 assessment and $50,000 criminal fine. Pursuant to Section 1760(e) of the Export Control Reform Act (‘‘ECRA’’),1 the export privileges of any person who has been convicted of certain offenses, including, but not limited to, 18 U.S.C. 371 and 18 U.S.C. 554, may be denied for a period of up to ten (10) years from the date of his/her conviction. 50 U.S.C. 4819(e). In addition, any Bureau of Industry and Security (‘‘BIS’’) licenses or other authorizations issued under ECRA, in which the person had an interest at the time of the conviction, may be revoked. Id. BIS received notice of Ball’s conviction for violating 18 U.S.C. 371 and 18 U.S.C. 554. As provided in Section 766.25 of the Export Administration Regulations (‘‘EAR’’ or the ‘‘Regulations’’), BIS provided notice and opportunity for Ball to make a written submission to BIS. 15 CFR 766.25.2 BIS has not received a written submission from Ball. Based upon my review of the record and consultations with BIS’s Office of Exporter Services, including its Director, and the facts available to BIS, I have decided to deny Ball’s export privileges under the Regulations for a period of five years from the date of Ball’s conviction. The Office of Exporter Services has also decided to revoke any 1 ECRA was enacted on August 13, 2018, as part of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, and as amended is codified at 50 U.S.C. 4801–4852. 2 The Regulations are currently codified in the Code of Federal Regulations at 15 CFR parts 730– 774 (2022). E:\FR\FM\10JAN1.SGM 10JAN1

Agencies

[Federal Register Volume 88, Number 6 (Tuesday, January 10, 2023)]
[Notices]
[Page 1353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00307]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-42-2022]


Foreign-Trade Zone (FTZ) 153--San Diego, California; 
Authorization of Production Activity; Ajinomoto Bio-Pharma Services 
(Pharmaceutical Products), San Diego, California

    On September 7, 2022, the City of San Diego, grantee of FTZ 153, 
submitted a notification of proposed production activity to the FTZ 
Board on behalf of Ajinomoto Bio-Pharma Services, within FTZ 153, in 
San Diego, California.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 56626, September 15, 2022). On 
January 5, 2023, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: January 5, 2023.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2023-00307 Filed 1-9-23; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.